1-(Methylthio)-3-octanone
Common Name: |
1-(Methylthio)-3-octanone |
IUPAC Name: |
1-methylsulfanyloctan-3-one |
Molecular Formula: |
C8H17NS2 |
SMILES: |
CCCCCC(=O)CCSC |
Inchi: |
1S/C9H18OS/c1-3-4-5-6-9(10)7-8-11-2/h3-8H2,1-2H3 |
Inchi Key: |
VBKCFHVICLIRLW-UHFFFAOYSA-N |
Cas No: |
61837-77-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
191.36 |
Mass (g/mol) |
174.108 |
Molar Refractivity |
60.35 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
1 |
Rings |
|
TPSA |
62.63 |
Hetero Atoms |
2 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
254.00 to 255.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.017 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
2.889 |
iLOGP |
2.65 |
XLOGP3 |
3.42 |
WLOGP |
2.35 |
MLOGP |
1.83 |
ESOL Log S |
-3.12 |
ESOL Solubility (mg/ml) |
0.147 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.42 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-1.89 |
Silicos-IT Solubility (mg/ml) |
2.45 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.04 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.652 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.191 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |